Abstract
To evaluate efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in treatment of patients with hepatocellular carcinoma. During January 2009 to March 2012, 80 patients with hepatocellular carcinoma underwent TACE, with or without RFA. Alfa- fetoprotein (AFP) was checked before and after procedure. CT scans were obtained one month after TACE or RFA for all patients to evaluate tumor changes. Complete response+partial response+stable disease (CR+PR+SD)/n were used to assess the disease control rate (DCR). Survival at 3, 6 and 12 months was compared in both groups. AFP levels in TACE + RFA group dropped rapidly, becoming obviously lower than that of the TACE group. In the TACE + RFA group DCR was 93.8%, while only 76.8% in the TACE group. The treatment effect between the two groups was statistically significant (P<0.05) by Ridit analysis. 1 year survival rate in the TACE + RFA group was 92.5%, significantly higher than that of the TACE group at 77.5% (P<0.05). TACE and RFA as combined therapy method for patients with middle and terminal stage HCC gives full play to synergy between the two and improves the therapeutic effect.
References
Oct 13, 1999·Seminars in Liver Disease·J M LlovetJ Bruix
Feb 27, 2001·AJR. American Journal of Roentgenology·S B ChinnD M Mahvi
Oct 11, 2001·Journal of Hepatology·J BruixUNKNOWN EASL Panel of Experts on HCC
May 2, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonAndrew X Zhu
Dec 8, 2009·Cardiovascular and Interventional Radiology·Ahsun RiazRiad Salem
Jan 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yun Ku ChoJin Wook Chung
Feb 13, 2010·Journal of Hepatology·Giacomo GermaniAndrew Kenneth Burroughs
Nov 12, 2010·Cardiovascular and Interventional Radiology·Eleni Liapi, Jean-Francois H Geschwind
Apr 21, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Chia-Yang HsuShou-Dong Lee
Feb 9, 2012·Journal of Hepatology·Marta BurrelJordi Bruix
Mar 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ju Dong YangJoong-Won Park
Jul 6, 2012·Nature·Timothy R WilsonJeff Settleman
Feb 23, 2013·Journal of Vascular and Interventional Radiology : JVIR·Rita GolfieriUNKNOWN Bologna Liver Oncology Group (BLOG)
Mar 4, 2014·Gastroenterology·Thomas YauRonnie T P Poon
Citations
Mar 2, 2016·World Journal of Experimental Medicine·Roberto MazzantiRenato Tassi
Feb 4, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Lin WangLi Li
Dec 3, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·De-Chao JiaoJian-Zhuang Ren
Mar 2, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Yang XiaoAi-Qin Ye